ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "PRO"

  • Abstract Number: 2707 • 2014 ACR/ARHP Annual Meeting

    Systemic Sclerosis Related Calcinosis: Patients Provide What Specialists Want to Learn

    Angela Christensen1, Samara Khalique2, Sophia Cenac3, Kim Fligelstone4, Anne Mawdsley5, Tracy Frech6, Jessica K. Gordon7, Murray Baron8, Evan Busman9, Virginia D. Steen10 and Lesley Ann Saketkoo11, 1Tulane University School of Medicine, New Orleans, LA, 2Louisiana State University Health Sciences Center, New Orleans, LA, 3Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University Health Science Center, New Orleans, LA, 4Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, 5Raynaud's & Scleroderma - Care and Support UK, Cheshire, United Kingdom, 6Div of Rheumatology, University of Utah, Salt Lake City, UT, 7Rheumatology, Hospital for Special Surgery, New York, NY, 8Pavillion A, Rm 216, Jewish General Hospital, Montreal, QC, Canada, 9Atlanta Scleroderma Support Group, Atlanta, GA, 10Department of Rheumatology, Georgetown University Medical Center, Washington, DC, 11Scleroderma and Sarcoidosis Patient Care and Research Center, Rheumatology and Pulmonary Medicine, Louisiana State University Health Sciences Center, New Orleans, LA

    Background/Purpose: Calcinosis is a disabling, rarely discussed manifestation of SSc for which the natural history and management is poorly understood.  Last year, the Scleroderma Clinical…
  • Abstract Number: 2416 • 2014 ACR/ARHP Annual Meeting

    Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain?  Implications for Clinical Practice

    Regan Arendse1, John Kelsall2, J. Antonio Avina-Zubieta3, Philip Baer4, Erica Weinberg4, Jude Rodrigues5, Algis Jovaisas6, Isabelle Fortin7, Maqbool Sheriff8, Majed M. Khraishi9, Emmanouil Rampakakis10, John S. Sampalis10, Francois Nantel11, Susan Otawa12 and Allen J Lehman12, 1University of Saskatchewan, Saskatoon, SK, Canada, 2The Mary Pack Arthritis Centre, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Private Practice, Scarborough, ON, Canada, 5Clinical Research and Arthritis Centre, Windsor, ON, Canada, 6194 Main Street, University of Ottawa, Ottawa, ON, Canada, 7Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 8Nanaimo Regional General Hospital, Nanaimo, BC, Canada, 9Nexus Clinical Research, Memorial University of Newfoundland, St Johns, NF, Canada, 10JSS Medical Research, Montreal, QC, Canada, 11Janssen Inc., Toronto, ON, Canada, 12Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose This analysis aimed to describe the pattern of specific joint involvement (tender and/or swollen) pre- and post-TNFi treatment and the impact of specific joint…
  • Abstract Number: 1551 • 2014 ACR/ARHP Annual Meeting

    Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction

    Denis Choquette1, Carter Thorne2, Majed Khraishi3, Isabelle Fortin4, Regan Arendse5, Andrew Chow6, John Kelsall7, Milton Baker8, Julie Vaillancourt9, John S. Sampalis9, Francois Nantel10, Allen J Lehman11, Susan Otawa11 and May Shawi10, 1Rheumatology, Notre Dame Hospital, Montreal, QC, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Nexus Clinical Research, St John's, NF, Canada, 4Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 5University of Saskatchewan, Saskatoon, SK, Canada, 6University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, 7The Mary Pack Arthritis Centre, Vancouver, BC, Canada, 8University of Victoria, Victoria, BC, Canada, 9JSS Medical Research, Montreal, QC, Canada, 10Janssen Inc., Toronto, ON, Canada, 11Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose The Health Assessment Questionnaire (HAQ) is commonly used for assessing patient-reported functional status and disease activity in psoriatic arthritis (PsA). However, it has been…
  • Abstract Number: 1522 • 2014 ACR/ARHP Annual Meeting

    Impact of Sarilumab on Health Related Quality of Life (HRQoL),  Fatigue, and Sleep in Rheumatoid Arthritis Patients at Week 24 – Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study

    Vibeke Strand1, George Joseph2, Hubert van Hoogstraten2, Chieh-I Chen3, Chungpeng Fan2, Paulo Carita4, Neil Graham3, Tanya Momtahen2 and Mark C Genovese5, 1Biopharmaceutical Consultant, Portola Valley, CA, 2Sanofi, Bridgewater, NJ, 3Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 4Sanofi, Chilly-Mazarin, France, 5Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA

    Background/Purpose: Sarilumab, a fully human monoclonal antibody directed against the IL-6 receptor, demonstrated efficacy in the phase 3 part of the RA-MOBILITY study (NCT01061736) in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology